S6.14.3 – Louise and Roger React to Empowered SLD Patient Advocates
After the roundtable, Louise Campbell and Roger Green share their reactions to the enthusiastic, empowered advocates who are the Harrison Fellows.
October 9, 2025
After the roundtable, Louise Campbell and Roger Green share their reactions to the enthusiastic, empowered advocates who are the Harrison Fellows.
In this conversation, the organizers of the Stephen A. Harrison Patient Advocacy Fellowship Program discuss their goals for the program.
In this conversation, we learn about how the Stephen A. Harrison Patient Advocacy Fellowship Program started and meet the program organizers and five of the initial Fellows.
Louise Campbell and Roger Green interview Wayne Eskridge and Elena Samsonova of the Fatty Liver Foundation and five of the first class of Harrison fellows about the new Dr. Stephen A. Harrison Patient Advocacy Fellowship program.
Louise Campbell drives this conversation, which focuses largely on issues related to MASH patient management. Her general point is that we need to take a more holistic look at MASH patient management, including self-management. Jörn Schattenberg and Roger Green share comments and questions.
Four leading US KOLs join Roger Green to discuss how the recent FDA approval of semaglutide in MASH will lead to dramatic changes in MASLD care in the US.
Predictive Health Intelligence Medical Director Tim Jobson joins Louise Campbell and Roger Green to provide an update on PHI’s Somerset project and other activities.
LiverRight CEO Brandon Tudor and Chief Medical Officer Alexander Lalos join Roger Green to discuss the launch of America’s first virtual hepatology clinic and the reason they created it.
First Six Months, Part I: Jörn Schattenberg cites two recent papers to describe the role proteomics might play in tailoring patient treatment plans.
In this conversation from April, Naim Alkhouri joins Roger Green to reminisce about his long relationship with Stephen Harrison and announce his (then) new role as Chief Academic Officer at Summit Clinical Research.